Why is Windlas Biotech falling/rising?

As of 15-Sep, Windlas Biotech Ltd's stock is currently priced at 1,000.00, reflecting a slight increase of 0.65 (0.07%). The stock has shown positive momentum recently, gaining for the last three days and outperforming its sector by 0.52%. Despite a 4.43% decline over the past month and a 3.24% drop year-to-date, the company has demonstrated strong performance over the last year with a return of 10.52%. Key financial metrics indicate positive results, including the highest quarterly net sales and profit before tax figures, alongside a low debt-to-equity ratio, suggesting a stable financial position. However, the stock is trading at a premium compared to its peers, which may affect its valuation perception.
In the broader market context, Windlas Biotech's recent performance contrasts with the Sensex, which has risen by 1.24% over the past week and 1.47% over the past month. While the stock has underperformed the benchmark in the short term, its long-term performance over three years shows a significant increase of 315.20%, indicating strong historical growth relative to the market. The rising investor participation, as evidenced by increased delivery volume, suggests a growing interest in the stock, which may contribute to its recent price stability despite broader market fluctuations.